HOLLANDA, L.; MONTEIRO, L.; MELO, A. Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial. Neurology International, v. 6, n. 4, 5 dez. 2014.